Radiation Oncology/Therapy: Page 370

C-11 topotecan PET shows promise for predicting therapeutic response
By Jonathan S. Batchelor
PET and PET/CT have demonstrated superiority in staging most cancers, depending on the radiopharmaceutical tracer used in the imaging study. The technology has also proved its strength in myocardial perfusion exams. The next frontier for the modality may be determining the efficacy of drug therapies for oncology patients, according to research presented at the 2006 Academy of Molecular Imaging (AMI) meeting in Orlando, FL.
April 20, 2006
Elekta to debut Axesse
By AuntMinnie.com staff writers
Swedish radiation therapy firm Elekta said it will unveil the latest product in its image-guided stereotactic radiosurgery line, the Elekta Axesse, at the American Association of Neurological Surgeons (AANS) conference this week in San Francisco.
April 19, 2006
Minrad revenues rise
By AuntMinnie.com staff writers
Minrad International reported first-quarter revenue of $3.1 million, up 29% compared with the $2.4 million turned in during the first quarter of 2004.
April 17, 2006
BrainLab gets FDA nod for iPlan Flow
By AuntMinnie.com staff writers
Image-guided surgery firm BrainLab has received U.S. Food and Drug Administration clearance for its iPlan Flow software.
April 16, 2006
Vital Images, R2 debut integrated lung CAD package
By AuntMinnie.com staff writers
Advanced visualization firm Vital Images and computer-aided detection (CAD) developer R2 Technology have introduced a new Vitrea package featuring integration with R2's ImageChecker CT lung CAD software.
April 16, 2006
Prostate health benefits from peppers, PSA screening
By Shalmali Pal
A new animal study by researchers from the U.S. and Japan found that capsaicin, the ingredient that gives chili peppers their kick, causes prostate cancer cells to self-destruct. Other studies by U.S. researchers examined the pathological characteristics of prostate cancers detected with prostate-specific antigen (PSA) testing, and the importance of PSA level after radiation therapy in predicting prostate cancer outcomes.
April 16, 2006
2006 04 14 16 28 38 706
Elekta, Impac notches U.K. IT order
By AuntMinnie.com staff writers
Swedish radiation therapy firm Elekta said it has received an oncology IT order from Guy's & St Thomas' NHS Foundation Trust in London, U.K.
April 11, 2006
American Shared to fund proton beam development
By AuntMinnie.com staff writers
American Shared Hospital Services of San Francisco has invested $2 million for an equity interest in Still River Systems, a proton beam radiation therapy (PBRT) development company in Littleton, MA.
April 10, 2006
Elekta, 3D Line Medical sign deal
By AuntMinnie.com staff writers
Swedish radiation oncology firm Elekta of Stockholm has signed a global marketing agreement with radiotherapy developer 3D Line Medical Systems of Milan, Italy.
April 6, 2006
NEMA paper touts imaging's role in oncology
By AuntMinnie.com staff writers
The National Electrical Manufacturers Association (NEMA) of Rosslyn, VA, and radiation therapy services firm US Oncology of Houston have released a new white paper on the role of medical imaging in the treatment and diagnosis of cancer.
April 5, 2006
Accuray cuts CyberKnife deal with Sinai
By AuntMinnie.com staff writers
Image-guided radiosurgery developer Accuray of Sunnyvale, CA, has sold its CyberKnife system to Sinai Hospital in Baltimore.
April 4, 2006
Siemens gets 510(k) for MVision
By AuntMinnie.com staff writers
Multimodality vendor Siemens Medical Solutions has received 510(k) clearance from the U.S. Food and Drug Administration for its MVision Megavoltage Cone Beam imaging package for radiation therapy applications.
April 3, 2006
Previous Page
Page 370 of 469
Next Page